Skip to main navigation Skip to search Skip to main content

Phase II study of everolimus and temozolomide as first-line treatment in metastatic high-grade gastroenteropancreatic neuroendocrine neoplasms

Siren Morken*, Seppo W Langer, Anna Sundlöv, Lene Weber Vestermark, Morten Ladekarl, Geir Olav Hjortland, Johanna B Svensson, Elizaveta Mitkina Tabaksblat, Torjan Magne Haslerud, Jörg Assmus, Sönke Detlefsen, Anne Couvelard, Aurel Perren, Halfdan Sorbye

*Corresponding author for this work
14 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Phase II study of everolimus and temozolomide as first-line treatment in metastatic high-grade gastroenteropancreatic neuroendocrine neoplasms'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science